Ledger.Open graph →
SEC Form D · filed September 10, 2020

Entasis Therapeutics Holdings Inc

Offering
$25.0M
Sold
$25.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Waltham, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

Michael Gutch · Waltham, MAExecDavid Hastings · Waltham, MADirectorJohn Mueller · Calgary, Alberta, CanadaExecHeather Behanna · Waltham, MADirectorDavid Altarac · Waltham, MAExecDavid Meek · Waltham, MADirectorElizabeth Keiley · Waltham, MAExecRuben Tommasi · Waltham, MAExecHoward Mayer · Cambridge, MADirectorHeather Preston · Redwood City, CADirectorManoussos Perros · Waltham, MAExec · DirectorMichael Gutch · Waltham, MAExecJohn Mueller · Overland Park, KSExecHeather Behanna · Waltham, MADirectorDavid Altarac · Waltham, MAExecDavid Meek · Waltham, MADirectorDavid Hastings · Waltham, MADirectorElizabeth Keiley · Waltham, MAExecRuben Tommasi · Waltham, MAExecHoward Mayer · Cambridge, MADirectorHeather Preston · Pleasanton, CADirectorManoussos Perros · Waltham, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗